ConductScience.org, home

Paper25473151

Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization.

Vercauteren K and 3 others. World J Gastroenterol, 2014. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization. Papers, record 25473151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25473151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization.
PubMed
Journal
World J Gastroenterol
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
0.68
iCite
Revised in PubMed
2024-10-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vercauteren KKoen
2Mesalam AAAhmed Atef
3Leroux-Roels GGeert
4Meuleman PPhilip

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, NeutralizingMajor topic
HepacivirusMajor topic
Hepatitis C AntibodiesMajor topic
Hepatitis C, ChronicMajor topic
LipidsMajor topic
LipoproteinsMajor topic
LiverMajor topic
Virus InternalizationMajor topic
Animals
Antiviral Agents
Host-Pathogen Interactions
Humans
Liver Transplantation
Treatment Outcome
Virulence
Virus Activation

Source PubMed

Download CSV of topics

References161

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116641285Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry.J Virol2006https://conductscience.org/library/papers/16641285PubMed
220568303Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy.Hepatology2010https://conductscience.org/library/papers/20568303PubMed
319793818Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles.J Virol2009https://conductscience.org/library/papers/19793818PubMed
419902246Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation.Med Microbiol Immunol2010https://conductscience.org/library/papers/19902246PubMed
522300469Antiviral strategies in hepatitis C virus infection.J Hepatol2012https://conductscience.org/library/papers/22300469PubMed
620826689Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms.J Virol2010https://conductscience.org/library/papers/20826689PubMed
717517063Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.Cell Microbiol2007https://conductscience.org/library/papers/17517063PubMed
818000990Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.Hepatology2007https://conductscience.org/library/papers/18000990PubMed
98121333Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins.Med Microbiol Immunol1993https://conductscience.org/library/papers/8121333PubMed
1019215577Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients.J Viral Hepat2009https://conductscience.org/library/papers/19215577PubMed
1117329325Human serum amyloid A protein inhibits hepatitis C virus entry into cells.J Virol2007https://conductscience.org/library/papers/17329325PubMed
1212483461Lipoprotein lipase: structure, function, regulation, and role in disease.J Mol Med (Berl)2002https://conductscience.org/library/papers/12483461PubMed
1317571164Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.J Clin Invest2007https://conductscience.org/library/papers/17571164PubMed
1412210409Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption.J Med Virol2002https://conductscience.org/library/papers/12210409PubMed
1515767578Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/15767578PubMed
1616476701The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins.FASEB J2006https://conductscience.org/library/papers/16476701PubMed
1719229312Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.PLoS Pathog2009https://conductscience.org/library/papers/19229312PubMed
1810535997Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10535997PubMed
1917215280Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity.J Virol2007https://conductscience.org/library/papers/17215280PubMed
2016356932Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes.J Biol Chem2006https://conductscience.org/library/papers/16356932PubMed

See all 161 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
41883448Very low-density lipoprotein and the human health.World J Exp Med2026https://conductscience.org/library/papers/41883448PubMed
41465470Epigenetic Mechanisms Involved in Hcv Infection and Human HCC.Int J Mol Sci2025https://conductscience.org/library/papers/41465470PubMed
35457118Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL).Int J Mol Sci2022https://conductscience.org/library/papers/35457118PubMed
35198567Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions.Front Cell Dev Biol2021https://conductscience.org/library/papers/35198567PubMed
33925362Hepatitis C Virus Uses Host Lipids to Its Own Advantage.Metabolites2021https://conductscience.org/library/papers/33925362PubMed
31178869A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice.Front Immunol2019https://conductscience.org/library/papers/31178869PubMed
29527256Hepatitis C virus: Morphogenesis, infection and therapy.World J Hepatol2018https://conductscience.org/library/papers/29527256PubMed
29158310Functional role of extracellular vesicles and lipoproteins in the tumour microenvironment.Philos Trans R Soc Lond B Biol Sci2018https://conductscience.org/library/papers/29158310PubMed
27338446Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance.Viruses2016https://conductscience.org/library/papers/27338446PubMed
26877603Hepatitis C virus relies on lipoproteins for its life cycle.World J Gastroenterol2016https://conductscience.org/library/papers/26877603PubMed
26420957Chronic hepatitis C virus infection and lipoprotein metabolism.World J Gastroenterol2015https://conductscience.org/library/papers/26420957PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25473151

GET https://conductscience.org/api/papers/v1/25473151/references?page=2